These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 14649887)

  • 1. Combination fusion protein therapy of refractory brain tumors: demonstration of efficacy in cell culture.
    Liu TF; Cohen KA; Willingham MC; Tatter SB; Puri RK; Frankel AE
    J Neurooncol; 2003 Oct; 65(1):77-85. PubMed ID: 14649887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DAB389EGF fusion protein therapy of refractory glioblastoma multiforme.
    Cohen KA; Liu T; Bissonette R; Puri RK; Frankel AE
    Curr Pharm Biotechnol; 2003 Feb; 4(1):39-49. PubMed ID: 12570681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diphtheria toxin-epidermal growth factor fusion protein and Pseudomonas exotoxin-interleukin 13 fusion protein exert synergistic toxicity against human glioblastoma multiforme cells.
    Liu TF; Willingham MC; Tatter SB; Cohen KA; Lowe AC; Thorburn A; Frankel AE
    Bioconjug Chem; 2003; 14(6):1107-14. PubMed ID: 14624623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-13 receptor-directed cytotoxin for malignant glioma therapy: from bench to bedside.
    Husain SR; Puri RK
    J Neurooncol; 2003 Oct; 65(1):37-48. PubMed ID: 14649884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Convection-enhanced delivery of interleukin-13 receptor-directed cytotoxin for malignant glioma therapy.
    Kioi M; Husain SR; Croteau D; Kunwar S; Puri RK
    Technol Cancer Res Treat; 2006 Jun; 5(3):239-50. PubMed ID: 16700620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth factor receptor expression varies among high-grade gliomas and normal brain: epidermal growth factor receptor has excellent properties for interstitial fusion protein therapy.
    Liu TF; Tatter SB; Willingham MC; Yang M; Hu JJ; Frankel AE
    Mol Cancer Ther; 2003 Aug; 2(8):783-7. PubMed ID: 12939468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interstitial diphtheria toxin-epidermal growth factor fusion protein therapy produces regressions of subcutaneous human glioblastoma multiforme tumors in athymic nude mice.
    Liu TF; Hall PD; Cohen KA; Willingham MC; Cai J; Thorburn A; Frankel AE
    Clin Cancer Res; 2005 Jan; 11(1):329-34. PubMed ID: 15671563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical studies with targeted toxins in malignant glioma.
    Rainov NG; Söling A
    Rev Recent Clin Trials; 2006 May; 1(2):119-31. PubMed ID: 18473963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-13 receptor as a unique target for anti-glioblastoma therapy.
    Husain SR; Joshi BH; Puri RK
    Int J Cancer; 2001 Apr; 92(2):168-75. PubMed ID: 11291041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting glioblastoma multiforme with an IL-13/diphtheria toxin fusion protein in vitro and in vivo in nude mice.
    Li C; Hall WA; Jin N; Todhunter DA; Panoskaltsis-Mortari A; Vallera DA
    Protein Eng; 2002 May; 15(5):419-27. PubMed ID: 12034862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of antiangiogenic targeted toxins against glioblastoma multiforme.
    Hall WA; Vallera DA
    Neurosurg Focus; 2006 Apr; 20(4):E23. PubMed ID: 16709029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that IL-13R alpha2 chain in human glioma cells is responsible for the antitumor activity mediated by receptor-directed cytotoxin therapy.
    Kawakami K; Kioi M; Liu Q; Kawakami M; Puri RK
    J Immunother; 2005; 28(3):193-202. PubMed ID: 15838375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The IL-4 and IL-13 pseudomonas exotoxins: new hope for brain tumor therapy.
    Shimamura T; Husain SR; Puri RK
    Neurosurg Focus; 2006 Apr; 20(4):E11. PubMed ID: 16709016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel anti-brain tumor cytotoxins specific for cancer cells.
    Debinski W; Gibo DM; Obiri NI; Kealiher A; Puri RK
    Nat Biotechnol; 1998 May; 16(5):449-53. PubMed ID: 9592393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution kinetics of targeted cytotoxin in glioma by bolus or convection-enhanced delivery in a murine model.
    Kawakami K; Kawakami M; Kioi M; Husain SR; Puri RK
    J Neurosurg; 2004 Dec; 101(6):1004-11. PubMed ID: 15597761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor-alpha-Pseudomonas exotoxin fusion protein (TGF-alpha-PE38) treatment of subcutaneous and intracranial human glioma and medulloblastoma xenografts in athymic mice.
    Phillips PC; Levow C; Catterall M; Colvin OM; Pastan I; Brem H
    Cancer Res; 1994 Feb; 54(4):1008-15. PubMed ID: 8313355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Convection enhanced delivery of IL13-PE38QQR for treatment of recurrent malignant glioma: presentation of interim findings from ongoing phase 1 studies.
    Kunwar S
    Acta Neurochir Suppl; 2003; 88():105-11. PubMed ID: 14531568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cintredekin besudotox in treatment of malignant glioma.
    Mut M; Sherman JH; Shaffrey ME; Schiff D
    Expert Opin Biol Ther; 2008 Jun; 8(6):805-12. PubMed ID: 18476792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of a restrictive receptor for interleukin 13 is associated with glial transformation.
    Debinski W; Slagle B; Gibo DM; Powers SK; Gillespie GY
    J Neurooncol; 2000 Jun; 48(2):103-11. PubMed ID: 11083073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Targeted therapy of malignant glioma by a chimeric fusion toxin composed of IL-13 and Pseudomonas exotoxin in vitro].
    Zhang JJ; Weng RG; Liu J; Chen HP; Liu J; Ye H; Zheng WM
    Zhonghua Yi Xue Za Zhi; 2012 Mar; 92(11):731-4. PubMed ID: 22781350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.